产品名称 | NebuSelect™ Recombinant Human LILRA2/CD85h/ILT1, His-tag |
---|---|
目录号 | NBL-241109 |
别名 | LILRA2/CD85h/ILT1 |
外观 | see COA |
分子量 | Gly24-Asn449 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q8N149-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241109-100ug | 100ug | Inquire | Inquire | |
NBL-241109-1mg | 1mg | Inquire | Inquire | |
NBL-241109-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human LILRA2/CD85h/ILT1, His-tag
Catalog#:
NBL-241109
Description:
NebuSelect™ Recombinant Human LILRA2/CD85h/ILT1, His-tag(Cat#NBL-241109) is expressed in HEK293 with His tag at the C-terminus.It contains Gly24-Asn449.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 48.54 kDa. Due to glycosylation, the protein migrates to 65-80 kDa based on Bis-Tris PAGE result.
Target Name:
LILRA2/CD85h/ILT1
Target Information:
LILRA2, also known as ILT1, CD85h, and LIR7, is an approximately 70 kDa variably glycosylated transmembrane protein that regulates immune cell activation. Mature human LILRA2 consists of a 426 amino acid (aa) extracellular domain (ECD) with 4 Ig-like domains, a 21 aa transmembrane segment, and a 13 aa cytoplasmic tail. LILRA2 is part of the innate immune responses against microbial infection.
Amino Acid Sequence:
Gly24-Asn449
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.